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Abstract 
Staphylococcus aureus is a commensal as well as pathogenic organism. The carriage rate of S. 
aureus has been estimated to be 20-30% among Palestinian population. Nasal colonization of 
this organism can potentially increase the risk of infections. In bacteria, Fe is a co-factor of many 
enzymes and has crucial role in man physiological processes such as DNA replication, 
transcription and metabolism. Iron acquisition is required for S. aureus colonization and 
subsequent pathogenesis. S. aureus employ different mechanisms to obtain iron through lysis of 
the red blood cells by hemolytic toxins and the production of siderophores and the consumption 
of heme from the host. 
Haptoglobin is an acute phase plasma protein that is synthesized primarily in the liver. There are 
two alleles expressing three different phenotypes, Hp1-1, Hp2-1 and Hp2-2. The polymorphism 
of haptoglobin has been associated with diseases in general and bacterial as well as other 
infections in particular.  The main function of haptoglobin is seen in its rapid binding and 
removal of hemoglobin from the circulation. The presence of free hemoglobin in the circulation 
released due to hemolysis of the red blood cells in-vivo or during storage prior to transfusion has 
been associated with vascular injury. 
This study was conducted on 1500 Birzeit university students, 26% males and 74% females. 
Nasal swabs whole blood were simultaneously obtained from all participants. Nasal swabs were 
cultured on mannitol salt agar to screen for the presence of S. aureus. Definitive identification of 
S. aureus was primarily done by tube coagulase and occasionally by Staphylase tests. 
Haptoglobin phenotyping was carried out by starch gel electrophoresis.  
Our results showed that 20% of tested students were carriers for S. aureus.  Haptoglobin 
polymorphism in S. aureus carriers was 12% Hp1-1, 34% Hp2-1 and 34% for Hp2-2. 
Haptoglobin polymorphism in control group was 10% Hp1-1, 44% Hp2-1 and 35% Hp2-2. 
xii 
 
Haptoglobin polymorphism was not detected in 20% of cases and 10% of the controls. Statistical 
analysis using Chi square by SPSS did not reveal any significant difference between the cases 
and controls. Allele frequency calculated for haptoglobin was 0.37 for the Hp1 allele in both 
cases and controls.  
The aims of this project were to determine the association of s. aureus nasal carriage with 
haptoglobin polymorphism. In addition, the allele frequency of haptoglobin gene was determined 
for the Palestinian study population. 
In conclusion, this study has provided new information regarding the status of haptoglobin 
among young Palestinians who carried S. aureus in their anterior nares as compared to non 
carriers. We recommend that this study should be expanded using equal numbers of males and 
females. In addition, it should also consider involving patients suffering from diseases such as 
renal failure, cardiovascular disease and diabetes.   
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 ملخص
. وكذلك لها القدره على التسبب بعديد من الامراض علي جسم الانسان، المتعايشةمن البكتيريا  المكورات العنقودية الذهبية تعتبر
من  البكتيريا ههذب الأنفي الاستعمار نسبةمع ارتفاع  .٪20-20في فلسطين من الناس الحاملين لهذه الجرثومه  معدل ويقدر
 .في العديد من الامراض العدوى خطرازدياد 
تكرار الحمض  مثل العمليات الفيسيولوجية دور حاسم في وله الإنزيمات للعديد من عامل مساعديعتبر عنصر الحديد 
لنمو وتكاثر البكتيريا بشكل عام والمكورات  الحديد يعتبر عامل اساسيالحصول عل  .والتمثيل الغذائي، ANDالنووي
كرات الدم الحمراء  تحلل من خلال الحديد مختلفة للحصول على آليات تستخدم والمكورات العنقوديه .العنقوديه بشكل خاص 
 .)serohporedis( وتستخدم اليات مختلفه للحصول على الحديد منها صنع مجسات مستلمه للحديد وتسمى
وله عن انتاج هذا ؤالمس الأليلات نوعان من هناك .في الكبد بشكل اساسي  يتم تصنيعه الذي بروتين البلازما هو الهابتوغلوبين
 .2-2pHو 1-2pH، 1-1pH :دعىمختلفة ت اشكال البروتين وينتج عن هذة الاليلات ثلاثة
بشكل  الأمراض المعدية الأخرى وكذلك البكتيرية بشكل عام والالتهابات  الأمراض بالعديد من  هابتوغلوبين تعدد اشكال ارتبط
حيث يساعد في .الدمويه  ةهي ازاله والتخلص من الهيموجلوبين الحر في الدورهابتوغلوبين وتعتبر الوظيفه الاساسيه  لل .خاص
 .الدمفي  بلازما  الحر الهيموجلوبينحماية الجسم من الكثير من الامراض التي يسببها  
الأنف  مسحاتبعد ان تم اخذ  .إناث٪ 74و  ذكور ٪20، بيرزيت جامعة طالب وطالبه في 2200 على هذه الدراسة أجريت
للكشف  ragA tlas lotinnaM على نفيةالأ تم زراعة المسحات .جميع المشاركين في البحث الدم في نفس الوقت  من وعينات
بواسطة فحص   ragA tlas lotinnaMكد من جميع البكتيريا النامية على  أتم التلقد ,. بكتريا المكورة العنقودية وجود عن
 .في بعض الاحيان  tset esalyhpatS بالاضافة الى  esalugaocانزيم التخثر
عينه لحاملين  700حاملين لهذه الجرثومه في الانف  ،تم تحليل جميع العينات  الطلاب ٪ من12أن  البحث نتائج أظهرت
وكانت  التعدد الشكلي للهابتوغلوبين عيينة اختيرت عشوائيا من الطلبة الغير حامليين للبكتيريا العنقوديه لتحديد 99و للجرثومه 
بين الطلبه الغير حاملين  الهابتوغلوبين تعدد الأشكال كان. 2-2pH%70و 1-2pH٪ 70، 1-1pH ٪00 .النتائج كالاتي 
 SSPS التحليل الإحصائي تم تحليل النتائج باستخدام برنامج.2-2pH٪ 00و  1-2pH ٪77، 1-1pH ٪20 للجرثومه هو
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ولا يوجد , وقد اثبتت الدراسه انه لا يوجد علاقه قويه بين تراكم البكتيريا العنقوديه بالانف ونوع الهابتوغلوبين الموجود بالدم 
في المجتمع الفلسطيني وتم مقارنته مع  selella pHتم احتساب  .اي فرق بين الطلبه الحامليين للجرثومه او الغير حاملين لها
 .%40ل   وكان مساوياالمجتعات في الدول المجاوره 
وتعدد اشكال الهابتوجلوبين في  العنقودية الذهبيةعلاقة بين الحاملين للمكورات لقد كان الهدف الاساسي لهذه الدراسة ايجاد 
 ycneuqerf selella pH.  تحديد اضافة لذلك تم. الجسم
المكورات  الذين حملوا الشبان الفلسطينيين بين هابتوغلوبين فيما يتعلق بوضع معلومات جديدة هذه الدراسة، قدمت وفي الختام
الذكور  أعداد متساوية من باستخدام أن يتم  توسيع هذه الدراسةب نوصي .الحاملين غير بالمقارنة مع الأنف في المذهبة العنقوديه
، ينبغي ربط التعدد الشكلي للهابتوجلوبين بالعديد من الامراض الاخري  مثل مرض السكري وبالإضافة إلى ذلك .والإناث
.والاوعيه الدمويه وامراض الكلى وامراض القلب 
Chapter 1 
Introduction 
1.1. Staphylococcus aureus 
S. aureus is a Gram positive coccus that has grape-like cluster morphology under the 
microscope. It is a commensal organism that resides in the skin, mucus membranes and the nose 
of healthy people. It has carotenoid pigment which gives the organism its characteristic golden 
yellow colonies during growth on rich media. The carotenoid pigment is considered a virulence 
factor which protects S. aureus from oxidants produced during the immune response. On media 
containing 5% sheep blood, S. aureus produces characteristic beta-hemolysis. S. aureus is a 
facultative anaerobic microorganism which is catalase positive, oxidase negative, coagulase 
positive, DNase positive and has tolerance to high concentrations of salt up to 1.7 M (Kaibni, 
Farraj, Adwan, & Essawi, 2009). 
S. aureus is a commensal as well as pathogenic organism. The carriage rate of S. aureus has been 
estimated to be 20-30% among Palestinian population. Nasal colonization of this organism can 
potentially increase the risk of infections. When transmitted to food from food handlers who are 
also carriers of S. aureus, it forms toxins in the food and causes food intoxication. S. aureus is a 
major cause of community and nosocomial infections, it is considered the second leading cause 
of nosocomial bacteremia (Klein, Smith, & Laxminarayan, 2007). Humans and animals are the 
natural reservoir for S. aureus.  S. aureus causes serious infection in hospitals and the community 
as well. Methicillin Resistant S. aureus (MRSA) have high mortality rates.  
Few studies have reported a rate of S. aureus nasal carriage among Palestinians living in 
different regions in Palestine of 25%. MRSA accounted for 9% of the S. aureus isolates(Adwan 
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et al., 2013; Kaibni et al. (2009)).This high rate of MRSA carriage  must be a priority for our 
medical  research  communities, due to the urgent need for  developing better prevention 
,diagnoses and treatment for infections with this pathogen. Since MRSA was first identified in 
1961, it was not until the mid-1980s when S. aureus developed resistance to methicillin through 
the mecA gene (located on a mobile genetic element). After that, S. aureus in general and MRSA 
in particular became a major concern for their rapid spread in hospitals causing hard to treat 
nosocomial infections and in the community as well causing community acquired infections. It 
has been reported the presence of different susceptibility profiles between these two types of 
infections. In addition, it was found that Panton-Valentine Leukocidin gene is more predominant 
among community acquired strains(Shrestha, Singh, Raj, Pokhrel, & Mohapatra, 2014).   
S. aureus has been considered one of the most common pathogens involved in causing  hospital 
acquired infections (Velazquez-Meza, Hernandez-Salgado, Contreras-Cordero, Perez-Cortes, & 
Villarreal-Trevino, 2013). The pathogenesis of S. aureus is mediated by the production of many 
virulence factors. Production of virulence factors is dependent on the nature of nutrients 
available in the growth medium. The type of nutrients present in the growth medium is usually 
sensed by S. aureus   and this can influence gene expression and the synthesis of virulence 
factors (Gilbert et al., 2013). 
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1.2. Staphylococcus aureus iron acquisition mechanism 
Iron (Fe) is one of the most abundant elements in the Earth's crust and the most abundant 
transition metal in the human body. Iron is a vital element for the survival, growth and 
proliferation of nearly all organisms, including pathogenic bacteria. In bacteria, Fe is a co-factor 
for many enzymes and has crucial role in man physiological processes such as DNA replication, 
transcription and metabolism (Hammer & Skaar, 2011). Iron acquisition is required for S. aureus 
colonization and subsequent pathogenesis. S. aureus employs different mechanisms to obtain 
iron through lyses of the red blood cells by hemolytic toxins and the production of siderophores 
and the consumption of heme from the host as shown in Figure1. Siderophores are iron 
chelating compounds produced by S. aureus that bind iron with high afﬁnity.  Siderophore  
acquisition  systems  have an important role in staphylococcal pathogenesis, or they may 
represent a method of acquiring iron in non-pathogenic settings, such as during commensal 
colonization of the nasopharynx or skin(Skaar & Schneewind, 2004). 
 
Figure 1: Staphylococcus aureus iron acquisition pathways(Hammer & Skaar, 2011) 
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1.3. Iron limitation and protection from bacterial infections  
There is an ongoing battle for iron acquisition between our immune system and bacterial 
pathogens in general and S. aureus in particular. This has led to the development of mechanisms 
to limit iron availability to the invading microbes in a process termed as “Nutritional Immunity”. 
Nutritional immunity is a term used to indicate withholding nutrients in order to inhibit bacterial 
growth. It is a form of defense mechanism adopted against microorganisms. The best example of 
nutritional immunity is intracellular sequestration of iron by ferritin, hemoglobin and myoglobin 
Figure 1. In addition, the free extracellular iron is usually insoluble and hence cannot be utilized 
by microorganisms(Hammer & Skaar, 2011). However,  Borrelia burgdorferi, the causative 
agent of Lyme disease has evolved a defense mechanism against iron sequestering by 
substituting manganese for iron in its metal requiring enzymes(Posey & Gherardini, 2000).  
Other pathogens including S. aureus have evolved mechanisms to circumvent iron sequestering 
via expressing high affinity receptors (Hammer & Skaar, 2011; Skaar, Humayun, Bae, DeBord, 
& Schneewind, 2004). 
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Figure 2: Fe limitation and Fe acquisition during bacterial infections (Hood & Skaar, 2012). 
 
 
 
1.4. Metal-dependent regulation 
Iron, magnesium, and manganese are metal ions that have a bacterial cofactor enzymatic 
function and in metabolism. These metals catalyze many biochemical reactions, maintain redox 
potential and produce harmful reactive oxygen species. Therefore, Bacteria have evolved 
mechanisms to maintain metal ion homeostasis.  S. aureus regulates iron ion homeostasis by the 
ferric uptake regulator (Fur) and iron storage and antioxidant protein regulator (PerR) systems 
(Horsburgh, Clements, Crossley, Ingham, & Foster, 2001; Wu et al., 2006). 
The main mechanism for S. aureus to obtain iron is siderophore-based iron acquisition which 
enables it to obtain iron from transferrin (Park, Sun, Choi, Bai, & Shin, 2005). It has been 
reported that defects in siderophore biosynthesis decrease the virulence of bacteria (Brozyna, 
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Sheldon, & Heinrichs, 2014). Regulation of siderophore biosynthesis and iron transport is 
mediated by ferric uptake regulator (Fur). Fur binds to or dissociates from a Fur promoter region 
on the DNA depending on the availability of iron (Horsburgh, Ingham, & Foster, 2001).When 
iron is present in a bacterium in high concentration; Fur binds to DNA and represses 
transcription of target genes. When iron concentration is very low, Fur dissociates in order to 
activate the target genes.  
PerR, in S. aureus, is a transcriptional repressor of peroxide resistance operons (Horsburgh, 
Clements, et al., 2001). PerR is a redox sensor that can sense hydrogen peroxide using Mn (II) as 
a co-repressor (Traore et al., 2009). Based on the level of Mn(II) and iron, PerR has different 
functions. The PerR regulon is repressed in the presence of Mn(II), whereas the regulon is 
derepressed in the presence of iron (Morrissey, Cockayne, Brummell, & Williams, 2004). 
1.5. Haptoglobin Synthesis and Structure  
Haptoglobin (Hp) is an acute phase protein that is synthesized by the liver and found in the 
plasma.  Hp synthesis is induced by cytokines produced during inflammation and in response to 
infections (Wang, Kinzie, Berger, Lim, & Baumann, 2001). Hp is composed of two chains, an 
alpha-chain (light) and beta-chain (heavy) that are linked by disulfide bonds between C131 on 
the alpha chain and C248 on the beta chain (Polticelli, Bocedi, Minervini, & Ascenzi, 2008). 
Three phenotypes of haptoglobin can be found in human plasma; Hp 1-1, Hp 2-1, Hp 2-2. As 
shown in Figure 3: Hp 2-1, Hp 2-2phenotypes exist as a series of polymers while the Hp 1-1 
phenotype exists as a homogeneous protein. The haptoglobin types differ in their alpha or light 
chains. Hp 1-1 contains only α¹ chain, Hp 2-2 contains only α² chain and Hp 2-1 contains α¹ and 
α² chains.  
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Figure 3: Subunit organizations of the major human Hp phenotypes 
 
Haptoglobin usually increases one day after the original challenge and remains elevated for up to 
two weeks (Jacobsen, Andersen, Toelboell, & Heegaard, 2004).The haptoglobin response is 
proportional to the severity of the challenge (Jacobsen et al., 2004; Vels, Rontved, Bjerring, & 
Ingvartsen, 2009). The time course and extent of haptoglobin response is in concordance with the 
primary role of haptoglobin to prevent further tissue damage and promote tissue repair (Petersen, 
Nielsen, & Heegaard, 2004). Haptoglobin accomplishes its function by acting as antioxidant, 
anti-inflammatory agent, tissue-regeneration agent, bacteriostatic, and by regulating the 
maturation and activity of immune cells. Thus, haptoglobin has been proposed as indicator of 
acute and chronic diseases; however, the sensitivity of haptoglobin for disease detection is 
limited (Horadagoda et al., 1999). Reasons for the limited sensitivity of haptoglobin have been 
studied in cows. It was found that not all cows have elevated haptoglobin concentrations during 
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disease. Haptoglobin concentrations decrease after acute infection and it’s response to tissue 
damage or infection is delayed (Horadagoda et al., 1999; Vels et al., 2009).The gene that encodes 
for haptoglobin is located on chromosome 16q22 (N. S. Levy et al., 2013; Polticelli et al., 2008). 
It consists of two main allelic forms; alpha-1 (1-1) that has 83 residues and alpha-2 (2-2) with 
142 residues Figure 4. Polymorphisms in these two alleles have three possible genotypes; 
homozygous (Hp1-1 or Hp2-2) and heterozygous (Hp2-1). Three phenotypes of Hp have been 
identified; two alleles for Hp1 designated Hp 1F (fast) and HP 1S (slow) and one allele for Hp2 
designated Hp 2FS. Hp1F and Hp1S alleles encode for exactly the same product except for one 
amino acid difference (Langlois & Delanghe, 1996).  Hp2 allele evolved from crossing over 
between Hp1F and Hp1S alleles but it encodes a longer product.  The Hp 2-2 phenotype has been 
associated with higher serum iron in healthy males only but not in females (Langlois, De 
Buyzere, Vlierberghe, & Delanghe, 2004; Langlois et al., 2000). 
 
 
 
Figure 4: Haptoglobin gene structure (Yano, Yamamoto, Miyaishi, & Ishizu, 1998). 
 
9 
 
1.6. Other Haptoglobin structures  
The existence of Hp structural variants have been recently  described (Carter & Worwood, 
2007). One variant,  Hp-Carlberg, identified in 1958 was associated with reduced synthesis of 
the α1S chain (Quaye, 2008). Other variants such as modified Hp2-1 referred to as Hp2-1M 
differs from Hp2-1 by its electrophoretic mobility. The Hp2-1M  phenotype has greater  number 
of Hp1 bands thus makes it heavier and more intense (Connell & Smithies, 1959). This 
phenotype is generated by the polymorphism of a single nucleotide in the promoter region of the 
Hp2 gene and is more frequent in African populations (Maeda, 1991). Giblett (1959) reported 
that the prevalence of this phenotype in North American Blacks in the Seattle region was 9.8% 
(Giblett, 1961; Thomsen, Etzerodt, Svendsen, & Moestrup, 2013). Azevedo et al. (1969) studied 
a population of 541 Afro-descendants from northeastern Brazil and found an association between 
the HP
α
2M allele and the presence of hypo-haptoglobinemia (Azevedo, Krieger, & Morton, 
1969). The rare Hp Johnson is the result of a crossover between the two Hp2 alleles and causes 
hypohaptoglobinemia or ahaptoglobinemia. The electrophoretic pattern of this phenotype 
consists of the Hp1 band and various polymers that migrate slowly (Langlois & Delanghe, 1996; 
Smithies, Connell, & Dixon, 1962) 
 1.7. Haptoglobin-Related Gene (Hpr) 
The Hp and haptoglobin related gene (Hpr) are located on chromosome 16 separated by 600 
nucleotides Figur5.  The Hpr gene sequence has evolved during evolution by gene duplication 
(Maeda, 1985). The Hpr gene sequence differs from that of the Hp gene by having inserted 
sequences from a retrovirus into the first intron. The entire Hp gene which includes the Hpr has 
94% sequence identity (Hardwick et al., 2014). The active promoter region of the Hpr gene 
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encodes a haptoglobin-related protein (Hpr) (Maeda, 1985). The concentration of the Hpr in the 
human serum is about 5%-10% of that of Hp protein in healthy people. 
The function of the Hpr protein is similar to that of the Hp protein in binding with high affinity 
the free hemoglobin found in the circulation. However, unlike Hp-Hb complexes, the Hpr-Hb 
complexes do not bind to the CD163 but remains in the circulation bound to apolipoprotein 
1(apol1)(Nielsen et al., 2006).  The Hpr plays an important role in protection in African 
population from Trypanosoma bruceibrucei infection due to its presence as part of the 
trypanosome lytic factor (TLF) (Maeda, 1985; Smith, Esko, & Hajduk, 1995). 
 
Figure 5: A schematic diagram of the genetic structure of the Hp
1
,Hp
2
 , and Hp
del
 alleles(Ko et al., 2013). 
Excess of free serum Hb usually occurs subsequent to extensive intravascular hemolysis. This 
results in the depletion of the Hp levels while the Hpr levels don’t differ significantly (Nielsen et 
al., 2006). The reason is the Hp-Hb complexes are internalized in the macrophages via the 
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CD163 receptor while the small amounts of Hpr-Hb complexes linger in the circulation bound on 
apol1.  
1.8. Hp0 Phenotype 
The Hp0 phenotype is characterized by the absence or reduced levels of Hp in plasma (Koda et 
al., 2000).  This phenotype  is genetically determined due to allelic deletion of the Hp gene in 
some individuals or low level of transcription in others  resulting  in conditions referred to as 
ahaptoglobinemia and hypohaptoglobinemia respectively         (J. Delanghe, Langlois, & De 
Buyzere, 1998; Koda et al., 2000). Secondary hypohaptoglobinemia can be caused by non-
genetic factors related to increased removal or reduced production of Hp during intravascular 
hemolysis and or liver diseases.  
The nature of the genetically determined hypohaptoglobinemia in East Asian population results 
from a 28 kb deletion referred to as Hp
Del
 that stretches from promoter region of the HP gene to 
exon 5 of the HPR gene. This deletion is usually found in patients diagnosed with 
ahaptoglobinemia who developed anaphylactic transfusion reactions caused by antibodies 
against haptoglobin (Koda et al., 2000). The ahaptoglobinemia or complete absence of serum Hp 
corresponds with the homozygous genotype Hp
Del
/Hp
Del
. The hypohaptoglobinemia or extremely 
low serum levels of Hp correspond with Hp2/Hp
Del
 genotype. The hypohaptoglobinemia or 
decreased levels (5o% less than normal) corresponds withHp1/Hp
Del
 genotype.  The frequency of 
Hp
Del
 gene is found among the Japanese and South East Asians, are between 0.15 and 0.30 
(Koda et al., 2000) and 0.8 among Mongolians (Soejima, Koda, Fujihara, & Takeshita, 2007). 
This genotype has not been identified in other Asian populations from Central, Southeast, South 
and West Asia. The lack of detection of the Hp
Del
 among these Asian populations can be due to 
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the sample size or the extinction of the Hp
Del
 allele. It has been reported that Hp
Del
 originated in 
China and then spread into Mongolia, Korea and Japan (Soejima et al., 2007). 
The Hp
Del 
allele has not been found in European and African populations. Congenital 
ahaptoglobinemia among these populations can be caused by mutations in the promoter region of 
the HP gene(Teye et al., 2003). The prevalence of the Hp0 phenotype among  Caucasians, is 
about 0.1% (Langlois & Delanghe, 1996), while  as high as 40% in Africans (Teye et al., 2006); 
the occurrence of this phenotype is influenced by acquired ahaptoglobinemia in areas where 
malaria is endemic and untreated (Boreham et al., 1979). In North Americans of African descent, 
the frequency of the Hp0 phenotype is ~2.3% (Carter & Worwood, 2007). 
1.9. Hemoglobin Structure and Function  
The hemoglobin (Hb) molecule is found in red blood cells and consists of four polypeptide 
chains or globins. There are two alpha and two beta chains (each carry heme molecule 
containing ferrous iron (Fe
++
). The structural and functional unit of adult hemoglobin is a 
tetramer of the 2 alpha and 2 beta chains binding together. Hb constitutes about one third of the 
mass of the red blood cell. The normal adult human hemoglobin is a mixture of 96-98% 
hemoglobin A ( (and  0.5-0.8% HbF (.  
The normal function of Hb is the transport of oxygen from the lungs to tissues and removing 
carbon dioxide from tissues to the lungs to be expelled during expiration (Schechter, 2008). The 
quaternary structure of Hb dictates its ability to bind oxygen in the lungs and release it in the 
tissues. In the lungs, oxygen binds to the ferrous iron of the heme molecule and released in 
tissues requiring oxygen.    
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Hb genes are located on different chromosomes. The beta globin genes are located on 
chromosome 11 while the alpha globin genes are located on chromosome 16 as shown in Figure 
6. 
 
Figure 6: Beta globin gene cluster (Bunn, 1986) 
 
1.10. Hemoglobin-Haptoglobin Binding 
The binding of haptoglobin to hemoglobin is a significant event.  Hemoglobin binding to 
haptoglobin was determined to occur on the alpha-chain of hemoglobin specifically on peptide 
121-135 (Kazim & Atassi, 1981). Recent evidence indicates that Hp preferentially binds to the 
beta subunits of hemoglobin. Haptoglobin is 2-acidic serum glycoprotein which form 
complexes with hemoglobin with very high binding affinity (Kd = 10
-12 
M)(Polticelli et al., 
2008). It is present in most body fluids in human and other mammals. The levels of Hp is usually 
increased during inflammation and malignancies but decreased during hemolytic conditions 
(Dobryszycka, 1997). 
The main function of haptoglobin is seen in its rapid binding and removal of hemoglobin from 
the circulation. The presence of free hemoglobin in the circulation released due to hemolysis of 
the red blood cells in-vivo or during storage prior to transfusion has been associated with 
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vascular injury (Vermeulen Windsant et al., 2012). Hemoglobin ability to bind nitric oxide (NO) 
can inhibit NO signaling. In addition, haptoglobin binding to free hemoglobin inhibits its 
oxidation and thus prevents acute kidney injury (Schaer, Buehler, Alayash, Belcher, & 
Vercellotti, 2013). Therefore, haptoglobin can be considered as potential therapeutic agent for 
conditions involving acute and chronic hemolysis of erythrocytes (Schaer et al., 2013). The 
removal of Hp-Hb complex from the circulation is mediated through binding to the scavenger 
receptor CD163 Figure 7 carried on peripheral blood cells and tissue monocytes and 
macrophages (Buehler et al., 2009). The ability of haptoglobin to deprive microorganisms from 
iron needed to cause infections and its binding to free hemoglobin endows haptoglobin 
additional properties as an antibacterial agent and an antioxidant. Other heme binding proteins 
are recognized and well described in literature such as Hemopexin and albumin which function 
in sequestering free heme. Hemopexin-Hb complex is removed from circulation by neutrophiles 
and macrophages via CD91receptor as shown in Figure 7 below (Ascenzi et al., 2005; Baker, 
Anderson, & Baker, 2003; Thomsen et al., 2013). 
 
Figure 7: Pathway for Hb-Hp complexes and hemopexin- (Hx) heme complexes uptake. Adopted from 
(Thomsen et al., 2013) 
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 1.11. Geographic Distribution of Haptoglobin Alleles 
The frequency of Hp genes among different populations is geographically dependent (Giblett, 
1961). The origin of the Hp2 allele for example has been originally reported in India and spread 
worldwide. This can be due to intense genetic pressure where the Hp2 allele became dominant 
and  may have a selective advantage over the Hp1 allele (Schultze & Heremans, 1966). The 
frequency and the geographic distribution of the Hp1 allele are evident in many countries such as 
Southeast Asia, Europe, African and America. The highest frequencies of Hp1 allele have been 
found among indigenous populations residing in South America (Nagel & Etcheverry, 1963; 
Schultze & Heremans, 1966; Sutton, Matson, Robinson, & Koucky, 1960). 
There is a state of constant equilibrium in the polymorphism of the Hp1/Hp2 throughout the 
world. Reports of allele frequencies of Hp1 and Hp2 vary between Europe and the American 
population Table 1. A frequency for Hp1 of 0.43 and0.54 and for Hp2 of 0.57 and 0.46 has been 
reported among European and American populations respectively (Langlois & Delanghe, 1996). 
The frequency of these two alleles had been studied among populations from southern and 
southeastern Brazil and revealed allele frequencies of 0.53 and 0.46 for Hp1 and 0.47 and 0.54 
for Hp2 respectively (de Souza et al., 2003; Zaccariotto et al., 2006). Shreffler and Steinberg 
(1967) reported frequencies of 0.48 and 0.47 for Hp1 and 0.52 and 0.53 for Hp2 among Xavante 
Indians living in central-western Brazil (Shreffler & Steinberg, 1967). Among Indians of the 
Amazon region in South America, Simoeset al. (1989) reported high frequencies of the Hp1S 
allele and low frequencies or complete absence of the Hp1F allele (Simoes et al., 1989). Several 
studies conducted to determine the frequency of the Hp alleles  among different populations 
worldwide is summarized in Table 1 and in Asian populations in Figure 8 
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. 
Figure 8: Hp1 Allele frequency among Asian population(Carter & Worwood, 2007)  
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Table 1:Hp1 gene frequencies in different populations .adopted from(Sonati, 2007).  
Continent Country Population studied No. Hp1 
allele 
frequen
cy 
Reference 
Africa 
 
Algeria 
(Sahara ) 
Saoura Valley region 
HoggarMontains region 
373 
260 
0.64 
0.66 
Constans  et . al . 
1981 
 Central 
African 
Republic 
Pygmies 
 Sahara region 
919 
280 
0.35 
0.53 
 Ghana General population 123 0.52 Teye et .al . 2006 
 Kenya Luo tribe (north of Lake Victoria) 227 0.57 Herzog et .al. 1970 
 Mali Menaka region 285 0.44 Constans 
et.al.1981  
 Nigeria Ibadan town 
 
 Zaria city 
63 
 
56 
 
0.73 
 
0.38 
Shirn and 
Bearn.1964 
Mastans et.al.1994  
 Sudan General population 208 0.54 Elagib et.al.1981  
 Senegal Bedik group 
Malinkes 
Peulhs 
733 
404 
169 
0.73 
0.64 
0.70 
Constans 
et.al.1981  
America  Brazil 
 
 
 
 
 
Two populations (Costa da Lagoa and 
Sao Joao do Rio Vermelbo ) from 
Santa Catarina  Island. southern Brazil   
{ descended from immigrants from the 
Azores Archipelago – ago( Portuguese 
) . with a minor contribution of sub –
Saharan Africans and Amerindians 
 
266 
 
 
 
 
 
0.52 and 
0.53 . 
respecti
vely  
 
 
 
Souza et.al.2003 
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Canada 
 
 
 
Caueasoids  and Afro-descendants 
from southeastern Brazil 
 
 
 
Eskimos from beffinIsiand 
 
Mixed(French-canadians-africans-
asians and others) 
 
 
 
 
142 
 
 
 
 
67 
 
358 
 
 
 
0.46 
 
 
 
 
0.24 
 
0.39 
 
 
 
 
 
Zaccariotto et 
.al.2006 
 
 
 
Shim and Bearn 
.1964 
Mahmoud 
et.al.1994 
 Chile Araucanian Indians 31 0.77 Shim and 
Bearn.1964 
 Colombia Spanish-origin population from Bogota 109 0.43 Mastana et.al.1994 
 USA Indian (Alabama Coushatta) 
 
Eskimos(northem and southem Alaska) 
 
General population 
143 
 
220 
 
3273 
0.37 
 
0.32 
 
0.39 
Shim and Bearn 
1964 
Scott et.al.1966 
 
Levy et.al.2004 
 
 
 
 
 Mexico Durango State(Urban Indians) 
 
Durango State(Isolated Indians: 
(Tepehuanos.Huicholes.Tarahumara 
119 
 
206 
 
0.63 
 
0.62 
 
 
Delanghe 
et.al.2000 
 
19 
 
and Mexicancros) 
 
Maya  Indian 
(Itza,Mam,Quiehe,Chol,Tzotzil,Tzeltal 
and Cakchiquel tribe) 
 
Maya (Lancandon tribe) 
 
Non-Maya Indians 
(Zapoteca.Chiapancea.Totonaca.Mestiz
o tribes) 
 
 
 
418 
 
 
31 
 
 
189 
 
 
From 
0.50 to 
0.69  
 
0.93 
 
From 
0.53 to 
0.67 
 
 
 
Sutton et.al.1960 
 Peru Cashinahua Indians 128 0.74 Johnston 
et.al.1969 
 Venezuela Piaroa Indians 
 
Makiritare Indians 
121 
 
186 
0.82 
 
0.49 
Marini et.al.1993 
 
Tanis et.al.973 
Asia Afghanistan Tajik group 
Pushtoons 
Hazaras 
Usbeks 
310 
210 
172 
124 
0.26 
0.26 
0.28 
0.25 
Rahimi et.al.1977 
 China Shenyang and Guangzou 
cities(northeastem and 
southemChina,respectively) 
 
General population 
 
Mongolian group 
 
57 
 
 
 
667 
 
204 
 
0.31 
 
 
 
0.33 
 
0.26 
 
Teye et.al.2006  
 
 
 
Ko et .al.1980 
 
Zhao et.al. 1993  
 
 India Bengalee Hindus(hetcrogeneous caste 140 0.19 Bandopadhaya 
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composition) 
Punjab(northern India)-jat Sikh group 
 
Punjab(northern India)-Khatri group 
 
 
Punjab(northern India)- Balmiki group 
 
Hindus from Hyderabad 
 
192 
 
105 
 
 
108 
 
 
116 
 
0.23 
 
0.19 
 
 
0.14 
 
 
0.20 
et.al.1992 
Kaur et .al.1981 
 
 
 
Mastana et.al.1994 
 Israel General population 757 0.33 Lavie et .al.2003 
 Japan Mixed(two different Japanese 
population) 
General population 
1211 
 
372 
0.26 
 
0.27 
Shindo . 1990 
 
Nakada and Abe 
1987 
 
 
 Jordan Jordanian Afro-descendants 
 
 
 
 
General population 
163 
 
 
 
 
200 
 
0.36 
 
 
 
 
0.29 
(Janaydeh, 
Hamad, & 
Awadallah, 
2004)Janaydeh 
et.al.2004 
Awadallah and 
Hamad.2003) 
 
 
 Korea General population(male athletes) 
 
General population 
120 
 
316 
0.31 
 
0.32 
Kang et.al.2003 
 
Yang et.al.2000 
 Malaysia General population 231 0.30 Saha and Ong 
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1984 
 Russia Chukotka Evens(northeastem Russia) 314 0.39 Solovenchuk and 
Glushenko 1985 
 Thailand North-central and northeastem 
areas(male members of the Royal Thai 
Army) 
 
General population (blood donors) 
682 
 
 
 
200 
0.24 
 
 
 
0.25 
 
Blackwell and 
Thephusdin.1963 
 
 
Shimada 
et.al.2007 
 
 Turkey General population 200 0.27 Erdem and Aksoy 
1997 
 
 Ukraine Mixed (from Dnepropetrovsk 
.Kharkov.Odessa.Kiev.Uzhgorod.Zhito
mir) 
596 0.38 Nikolchcnko et.al. 
1997 
Europe Belgium General population 918 0.40 Van Vlierberghe 
et.al. 2001 
 Germany Hamburg (northern Germany) 1725 0.39 Kruger and 
Puschel 1993 
 Greece Northern Greece 212 0.35 Stromatias 
et.al.1987 
 Hungary Budapest 
 
General population 
343 
 
384 
0.35 
 
0.35 
 
Hever 1976 
 
Papp et.al.2007 
 Italy Continental Italy (north 
eastern,northwestern,central and 
southern regions) 
Sardinia 
441 
 
 
165 
0.11 
 
 
0.18 
Santoro et.al.1983 
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 Moldavia Gaugauz 190 0.35 Varsahr et.al.2001 
 Norway Oslo 6668 0.38 Teige et.al.1992 
 Spain Barcelona 317 0.38 Moral and 
Panadero 1983 
 United 
Kingdom 
Northeastern England 
 
 
Southern Wales 
101 
 
 
265 
0.41 
 
 
0.40 
Mastana et.al.1994 
 
 
Carter et.al.2003 
 
 
Oceania Australia Caucasian population 
 
Aborigenes from Amhem Land 
 
Aborienes from westem desert 
307 
 
50 
 
101 
0.40 
 
0.29 
 
0.19 
Lai et.al.1976 
 
Shim and 
Bcarn.1964 
 Micronesia Marshall Island 364 0.52 Neel et.al.1976 
 Papua New 
Guinea 
Southern Highland 
Eastern  Highlands 
Western Highlands 
North Coast 
99 
59 
24 
22 
0.80 
0.53 
0.87 
0.64 
Hill et.al.1986 
 Vanuatu Espiritu Santo 
Pentecost 
Emae 
Central  group 
Tanna 
Futuna 
Aneityum 
79 
101 
60 
70 
47 
32 
46 
0.73 
0.68 
0.63 
0.61 
0.71 
0.69 
0..61 
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1.12. Haptoglobin Functions  
Haptoglobin synthesis occurs mainly in the liver and in fewer amounts in the adipose tissue and 
lungs as well. The function of haptoglobin is seen in playing significant role as antioxidant and 
in antimicrobial activity. Haptoglobin plays a role in stimulation of angiogenesis and has highly 
potent cholesterol crystallization-promoting activity. Probably the most important biological 
function of haptoglobin has been manifested in the host defense responses to infection and 
inflammation, acting as a natural antagonist to receptor-ligand activation of the immune system. 
The functions of the Hp phenotypes are related to the various biochemical and biophysical 
characteristics, as well as their functional efficiencies which determine their specific antioxidant 
and immunomodulatory capacities Table 2 (Langlois & Delanghe, 1996; H. K. Louagie, 
Brouwer, Delanghe, De Buyzere, & Leroux-Roels, 1996). The main biological functions of Hp 
are discussed in the following sections. 
Table 2:  Functional  properties  of Hp phenotypes(Langlois & Delanghe, 1996) 
Function  Hp1-1 Hp2-1 Hp2-2 
Hemoglobin   binding Strong intermediate Weak 
Antioxidative  capacity Strong intermediate Weak 
Inhibition   of  
prostaglandin  
synthesis 
Strong intermediate Weak 
Angiogenic     effect Weak intermediate Strong 
Agglutination   of ------- intermediate Strong 
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1.12
.1. Haptoglobin-Hemoglobin binding and renal failure protection  
Free hemoglobin released from RBCs highly toxic and mediates iron-driven oxidative stress and 
inflammation (Tseng, Lin, Huang, Liu, & Mao, 2004). It is known that the role of Hp is the 
removal of free Hb released during intravascular hemolysis. The Hp-Hb binding is irreversible, 
non-covalent and the complexes are soluble as characterized by high stability and affinity at 1 x 
10
-15
mol L
-1
(Okazaki, Yanagisawa, & Nagai, 1997). Studies suggested that Hb-β chain has two 
Hp binding sites (residues β11-25 and b131-146) whereas the α-chain has only one Hp binding 
site (residues α121-127). The dimers of Hb αβ  and Hpαβ subunits bind stoichiometrically 
(Langlois & Delanghe, 1996). Circulating haptoglobin reaches saturation at a free Hb 
concentration of 500-1500 mg L-
1 
(Van Vlierberghe, Langlois, & Delanghe, 2004). 
The free Hb released from lysed RBC’s is removed by glomerular filtration possibly resulting in 
renal damage. The role of Hp in binding Hb and iron is protective from renal damage because the 
Hp-Hb complex is not filtered through the glomeruli (Langlois & Delanghe, 1996; Van 
Vlierberghe et al., 2004). Most of the Hp-Hb complex (90%) is removed from the circulation by 
hepatocytes while 10% is removed by tissue monocytes/macrophages. Although the receptor for 
the Hp-Hb complex on hepatocytes has not been well characterized, but it has a high affinity for 
binding the Hb-Hp complex (Kino et al., 1980). The receptor for Hb-Hp has recently been 
identified in macrophages as CD163 (Horn et al., 2003; Kristiansen et al., 2001). The Hb-Hp 
Streptococcus 
pyogenes14 
Affinity  towards  
CD22 
Strong Strong Strong 
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complex is usually enters the lysosomes via endocytosis and subsequently broken down. 
Although haptoglobin is not recycled, heme is degraded by heme-oxygenase (HO) to release 
iron, which is utilized in the synthesis of other proteins (Van Vlierberghe et al., 2004). 
Interleukin-6 has an important role in the regulation of this process because it stimulates Hp 
production and  increases the expression of CD163 in macrophages increasing  the efficiency of 
Hb-heme group degradation (Dennis, 2001). 
1.12.2. Reduction of free toxic radicals  
Free iron can react with oxygen (O2) via the Fenton reaction to generate superoxide, and with 
H2O2 to produce hydroxyl free radicals (Kaplan, 2002). The harmful effects of LDL are 
catalyzed by free iron thus causing vascular and endothelial cell damage (Grinshtein, Bamm, 
Tsemakhovich, & Shaklai, 2003). The damage to the vascular system by free radicals can be 
reduced by haptoglobin. This reduction is highly dependent on Hp phenotypes (Gutteridge, 1987; 
Van Vlierberghe et al., 2004). It has been reported that Hp1-1 provides greater protection against 
oxidative damage in vitro (Koda, Soejima, Yoshioka, & Kimura, 1998; Koda et al., 2000). The 
three Hp phenotypes have the same binding affinities for Hb (Melamed-Frank et al., 2001). 
Variations in size between the   proteins play a role in their ability to prevent the release of heme. 
Since Hp2-2 phenotype is larger in size, it removes iron to the extravascular space more slowly. 
This causes greater oxidative stress in individuals who carries the Hp2-2 phenotype whose free 
Hb remains for longer time in the circulation (Melamed-Frank et al., 2001).  
1.12.3. Nitric Oxide inhibition  
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Nitric oxide (NO) is a highly reactive gas produced by various cells such as endothelial cells and 
macrophages (Hibbs, Taintor, Vavrin, & Rachlin, 1988). NO is originally referred to as 
endothelium-derived relaxing factor (EDRF). The role that NO gas plays in the human body 
includes the maintenance of vascular tone and modulation of neurotransmitter function in the 
central and peripheral nervous systems, platelet aggregation and cellular defense (Green, 1995; 
Moncada & Higgs, 2006; Sadrzadeh & Bozorgmehr, 2004). Free Hb and Hp-Hb complex 
inactivate NO/EDRF, whereas Hp alone doesn’t. Consequently, an increase in the level of 
circulating Hp-Hb may inhibit NO formation and endothelium relaxation, thereby enhancing the 
risk of cardiovascular disease (Moncada & Higgs, 2006). The Hp1-1 phenotype may be 
advantageous in this respect because the Hp1-1: Hb complex is removed from circulation more 
rapidly than the other Hp complexes (Melamed-Frank et al., 2001; Saeed, Ahmad, & Ahmed, 
2007). 
1.12.4. Hp phenotypes effects on immune system  
As an acute phase protein, Hp production is usually enhanced during inflammation, infection or 
tumor growth. Hp participates actively in several processes of the immune response, from 
activation of the innate and adaptive immune responses to tissue repair and regeneration (Quaye, 
2008).It has been well documented that Hp has immunoregulatory properties, with Hp2-2 
individuals showing greater immunological reactivity (including greater production of antibodies 
after vaccination) than individuals with Hp1-1 and Hp2-1 phenotypes(Langlois & Delanghe, 
1996; S. S. Nevo & Sutton, 1968). In addition, haptoglobin has anti-inflammatory properties thus 
inhibits prostaglandin synthesis. It is noticeable that these anti-inflammatory properties are less 
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pronounced in Hp2-2 individuals (Braeckman, De Bacquer, Delanghe, Claeys, & De Backer, 
1999; Langlois & Delanghe, 1996). 
In the presence of haptoglobin which is considered a powerful suppressor of lymphocyte 
function, lymphocytes are unable to proliferate in the presence of the mitogens 
phytohemagglutinin and concanavalin A (Baseler & Burrell, 1983). The immune response is 
induced and regulated by T helper (Th) subsets specifically Th1 (cellular response) and Th2 cells 
(humoral response). The production of IL-2 and interferon gamma (IFN-γ) by Th1 cells induces 
strong IgG responses, thus favoring the cellular immune response. On the other hand, Th2 cells 
produce IL-4, IL-5, IL-6, IL-10 and IL-13 increasing IgE production, thereby mediating a 
predominantly humoral and eosinophilic response Hp plays a role in modulating the balance 
between Th1 and Th2 lymphocytes by mainly promoting Th1 cell response(M. Arredouani et al., 
2003). Both Th subsets are more effective in protecting against infections involving intracellular 
parasites and inhibit the release of Th2 cytokines responsible for defense against extracellular 
microorganisms. (M. S. Arredouani et al., 2005) reported that Hp modulates the inflammatory 
response by suppressing the synthesis of TNF-α, IL-10 and IL-12 by Lipopolysaccharides 
stimulated monocytes. Recent research by Guetta et al. (2007), correlated the increased 
production of cytokines (IL-6 and IL-10) by Hp1-1-Hb complex formation as compared to Hp2-
2-Hb. The release of these cytokines is dependent on the binding of the Hp-Hb complexes to the 
CD163 receptors on macrophage. Based on this, it was suggested that Hp1-1 is more protective 
against vascular damage than Hp2-2 (Guetta, Strauss, Levy, Fahoum, & Levy, 2007). 
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 1.12.5. Angiogenesis 
Angiogenesis occurs under normal (healthy) as well as pathological conditions. Haptoglobin has 
the ability to stimulate angiogenesis (serum angiogenic factor) and promote endothelial cell 
proliferation and differentiation (Dobryszycka, 1997). Hp is also involved in cell migration and 
restructuring of the arterial walls (de Kleijn et al., 2002). The ability of haptoglobin in 
stimulating tissue repairs and promoting angiogenesis in ischemic conditions is useful for 
treating chronic inflammatory conditions. It is noteworthy that Hp2-2 is more antigenic than the 
other Hp phenotypes (Cid et al., 1993) . 
1.13. Haptoglobin Phenotyping 
The levels of Hp in human are generally stable but can change with age. Some variations in Hp 
concentrations are reported in the following decreasing order Hp1-1 > Hp2-1 > Hp2-2 (Imrie et 
al., 2006; Langlois & Delanghe, 1996). The level of Hp in fetuses, cord blood and neonates is 
usually very low. Investigation on ahaptoglobinemia among Brazilian neonates  was found in 
only 8% with Hp1-1 as the predominant phenotype    (de Azevedo, Salzano, & Azevedo, 1974). 
Different methods are usually used to determine the concentrations of haptoglobin levels in 
plasma. Initially the ability of plasma to bind Hb was used. The radialimmunodiffusion method 
is the simplest quantifying technique for Hp (Mancini, Carbonara, & Heremans, 1965). 
Currently, the immunonephelometric and immunoturbidimetric assays are widely used to 
quantify Hp (Ramakers & Kreutzer, 1976). 
Methods for haptoglobin phenotyping have followed an electrophoretic separation of the 
different phenotypes based on their molecular size and mobility in an appropriate gel medium 
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(Santoro, Boccazzi, & Carbonara, 1982). Starch gel electrophoresis was first developed in 1955 
by (Smithies, 1955). This method was able to separate and specifically identify the three major 
Hp phenotypes. This method relied mainly on staining the separated phenotypes by peroxidase 
staining based on the order of their mobility in the starch gel, Hp1-1 is the smallest and fastest to 
migrate forming a single band. Hp2-2 protein is slowest and forms distinct large bands. 
However, the Hp2-1 phenotype forms a series of bands located between the Hp1-1 and Hp2-2 
bands (Langlois & Delanghe, 1996). Polyacrylamide gel electrophoresis (SDS-PAGE) is another 
method that can be used for Hp phenotyping. Acrylamide Gel give higher resolution and can be 
used instead of starch gels (Peacock, Bunting, & Queen, 1965). Molecular methods, such as the 
polymerase chain reaction (PCR), have been recently used to genotype haptoglobin (N. S. Levy 
et al., 2013; Yano et al., 1998) Genotyping methods have advantages over other methods for 
their high specificity and sensitivity thus can detect minute amounts of circulating haptoglobin 
(J. R. Delanghe & De Buyzere, 2004) . 
1.14. Association of Hp Polymorphism with diseases  
Genetic polymorphism of haptoglobin and associated function has triggered further 
investigations to determine the influence of Hp subtypes in different human pathologies (Carter 
& Worwood, 2007). Haptoglobin polymorphism plays a significant role in parasitic, bacterial, 
and viral infections. Although the effect of haptoglobin polymorphism in many  infectious 
conditions, but this effect is not always predictable due to the multifunctional character of the 
plasma protein (e.g., antibody-like properties, immunomodulation, iron metabolism) (Kasvosve, 
Speeckaert, Speeckaert, Masukume, & Delanghe, 2010). Several studies illustrated the 
correlation between haptoglobin phenotype and different kind of disease. There is a strong 
30 
 
association between different haptoglobin phenotypes and the types of diseases such as  
cardiovascular disease, autoimmune disorders and malignancy. Certain types of  haptoglobin 
present can provide protection from the development of these diseases (Wassell, 2000). Hp 2-2 
phenotype has been associated with atherosclerosis in hypertensive patients. High levels of this 
phenotype has been found in younger patients (<45 years) and in patients with previous 
myocardial infarction (J. Delanghe et al., 1997). The Hp polymorphism has also been implicated 
with iron status (Langlois et al., 2000). It was reported that Hp 2-2 is associated with increased 
levels of iron, ferritin and transferring saturation in males. In addition, elevated serum ferritin 
was associated with higher intracellular concentration in monocytes and macrophages (Langlois 
et al., 2000) 
In DM, increased oxidative stress is common among diabetic patients resulting in glucose 
oxidation and modification of low-density lipoproteins (LDL). Such changes may stimulate the 
production of inflammatory cytokines which is implicated in morphological and pathological 
changes found in macrovascular and microvascular complications (Giugliano, Ceriello, & 
Paolisso, 1996). 
Research has determined that certain Hp phenotypes and their different antioxidant properties 
have different effects on the degree of susceptibility to develop vascular problems in diabetic 
patients. Individuals with Hp 1-1 show better protection against DM than Hp 2-1 and Hp 2-2 
individuals. This variation in oxidative capacity among Hp phenotypes is not associated with 
their Hb binding affinity; rather it is attributed to structural variations and the smaller size of 
Hp1-1 enabling it to pass more easily through the endothelial barrier to reach extravascular 
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spaces. Therefore, Hp 1-1 individuals are better protected against oxidative stress than Hp 2-1 
and 2-2 individuals (Asleh et al., 2012; A. P. Levy et al., 2002; Vardi, Blum, & Levy, 2012). 
The Hp phenotypes have been investigated and compared in patients with Type 2 DM patients 
and macro vascular complications and in normal individuals (A. P. Levy et al., 2002). It has been 
found that diabetic patients who carried the Hp2-2 phenotype were five times more likely to have 
cardiovascular complications as compared to those with the Hp1-1 phenotype. The risk of 
developing cardiovascular disease in these patients was intermediate in patients with   Hp2-1 
phenotype. These results are in agreement with reports indicating the protective role of the Hp1-
1phenotype against restenosis after coronary stent implantation in diabetic patients (Roguin et 
al., 2002). 
Research conducted by  Suleiman et al. (2005) reported that  diabetic patients with acute 
myocardial infarction have  demonstrated that the Hp1-1 phenotype was associated with smaller 
infarct size and lower mortality rates at 30 days (Suleiman et al., 2005). 
 Arterial elasticity indices were found to be significantly lower and the vascular resistance are 
higher in diabetic patients who carried the Hp2-2 phenotype as compared to patients who carried 
Hp2-1 and Hp1-1 phenotypes (Shor et al., 2007). Such findings indicate the presence of a major 
predisposition to the development of atherosclerosis in homozygotes for the Hp2 allele. 
It has been found that  microvascular complications in both types of DM has been associated 
with the Hp2-2 phenotype (Nakhoul, Miller-Lotan, Awaad, Asleh, & Levy, 2007). Previously, 
Nakhoul et al.(2000) reported that the Hp2-2 phenotype is overrepresented among Israelis with 
Type 1 DM patients who has diabetic retinopathy while Type 1 and Type 2 DM patients carrying 
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the Hp1-1 phenotype had greater protection against diabetic nephropathy (Nakhoul et al., 2000; 
Nakhoul et al., 2001). Similar findings has been reported by Bessa et al. (2007) for Egyptian 
patients with Type 2 DM (Bessa, Hamdy, & Ali, 2007). Koda et al. (2002), however, did not find 
this protective effect attributed to the HP1 allele among patients with Type 2 DM in Japan (Koda 
et al., 2002). 
Research has been conducted for many years to find an association between Hp phenotypes and 
heart disease.  Reports indicated the presence of significant increase in the incidence of the Hp 2-
2 phenotype in high-risk cardiac patients compared to the normal control group (Gogishvili, 
Kavtaradze, Mamaladze, Arutiunova, & Takadze, 1985). In 1982, Chapelle et al. found that the 
severity of damage post  myocardial infarction was greater in patients with Hp2-2 than in 
patients carrying the Hp1-1 or Hp2-1 phenotypes (Chapelle, Albert, Smeets, Heusghem, & 
Kulbertus, 1982). Additionally, in patients with the Hp 2-2 phenotype who underwent a coronary 
artery bypass graft, the survival time was shorter than for patients with other Hp phenotypes. 
This can be due to the accumulation of atherosclerotic lesions in essential hypertension (J. 
Delanghe et al., 1997). 
It has been established that the Hp 2-2 phenotype is an independent genetic risk factor for the 
development of coronary atherosclerosis (Stein & McBride, 1998; Van Vlierberghe et al., 2004). 
The reason for that could be due to the inability of this phenotype to provide protection against 
oxidative stress in arteries of patients with atherosclerotic plaques. It has also been considered to 
be a risk factor for developing refractory hypertension; therefore these patients with this 
phenotype require more complex antihypertensive drugs to control their blood pressure (J. R. 
Delanghe et al., 1995). In addition, individuals with the Hp2-2 phenotype have higher serum 
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cholesterol levels compared with individuals carrying other Hp phenotypes (Braeckman et al., 
1999). This indicates that the different functions of Hp may be used to predict the susceptibility 
to cardiovascular disorders and patient prognosis. 
In literature, reports have correlated specific Hp phenotypes with cancer (Bartel, Elling, & 
Geserick, 1985). The Hp 1-1 has been shown to be more prevalent in women with breast tumors 
(Awadallah & Atoum, 2004). They concluded that the Hp 1 phenotype is more common among 
familial cases while the Hp2 phenotype is not. Furthermore, it has been found that the Hp1 gene 
is overrepresented in cases with ovarian carcinoma (Dobryszycka & Warwas, 1983). However, 
an association between the Hp2-1 phenotype and a family history of ovarian carcinoma has been 
reported (Frohlander & Stendahl, 1988). 
It is apparent that each Hp phenotype is more common with certain malignancies. The Hp 2-2 for 
example has been found in lower frequency in patients with pulmonary adenocarcinoma and 
bladder carcinoma than in normal controls(Beckman, Eklund, Frohlander, & Stjernberg, 1986)  
On the other hand,  the Hp2-1 and Hp2-2 phenotypes were found in significantly higher 
frequency in patients with esophageal and gastric cancers(Jayanthi et al., 1989). 
The correlation between Hp phenotypes and different types of leukemia has also been 
investigated. The Hp 1-1 phenotype has been detected in patients with  acute lymphatic (ALL), 
acute myeloid (AML) and chronic myeloid (CML) leukemia (S. Nevo & Tatarsky, 1986).  
However, Frohlander (1984) did not observe any association between Hp phenotypes and 
leukemia but ahaptoglobinemia was significantly more frequent in these patients (Frohlander, 
1984). In another study, a low frequency of Hp2-2 has been observed in patients with IgA 
myeloma (Germenis, Babionitakis, Kaloterakis, Filiotou, & Fertakis, 1983). 
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It has been demonstrated in literature that Hp polymorphism may play a role in a number of 
infectious diseases. One of the known functions of haptoglobin is the prevention of bacterial 
growth by removing free iron. This natural bacteriostatic property has affected the growth of 
some bacterial pathogens such as Neisseria meningitides, Campylobacter jejuni and Bacteroides 
fragiles (Eaton, Brandt, Mahoney, & Lee, 1982; Lewis & Dyer, 1995; Pickett, Auffenberg, 
Pesci, Sheen, & Jusuf, 1992). Earlier studies showed that haptoglobin provided protection to rats 
that has been inoculated with pathogenic Escherichia coli and Hb (Eaton et al., 1982). In cases 
with tuberculosis, it has been reported that the death rate was 6.1 times higher in patients who 
carried the Hp2-2 phenotype than those with the Hp 1-1 (Kasvosve et al., 2000). 
In HIV viral infections, cell to cell viral transmission is mediated by families of integrin adhesion 
receptors such as CD11a-c and CD18 which was found to contribute to variations in the survival 
rates. In HIV-seropositive patients, the   circulating plasma iron could enhance Hb-driven 
oxidative stress which favors viral replication and transmission. Delanghe et al.in 1998 reported 
a correlation between HIV-seropositive patients with Hp2-2 phenotype and higher mortality and 
worse prognosis than patients with other phenotypes (J. R. Delanghe et al., 1998). 
Chronic hepatitis C infections has been associated with Hp polymorphism (Hp1-1 was 
overrepresented)(H. K. Louagie et al., 1996). Such  finding may indicate  that Hp phenotype may 
affect  the clinical evolution of hepatitis C. Interestingly; Hp2-2 individuals develop lower levels 
of antibodies after vaccination against hepatitis B than those with Hp1-1 or Hp2-1 phenotypes(H. 
Louagie et al., 1993) . 
In Sudanese patients infected with Plasmodium falciparum,  significant increase in the levels of  
Hp1-1 in  patients with uncomplicated and complicated forms of the disease has been reported 
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(Elagib, Kider, Akerstrom, & Elbashir, 1998). The phenotype frequency   among these patients 
was 60.8% for Hp1-1, 29.7% for Hp2-1 and 9.5% for Hp2-2. In healthy (control) individuals 
from the same region, phenotype frequency was 26.0%, 55.8% and 18.3%, respectively. Hp1-1 
phenotype was also predominant among patients with severe P. falciparum malaria living in the 
coastal region of Ghana (Quaye, Brandful, Ekuban, Gyan, & Ankrah, 2000). Consistent with 
these reports associating the prevalence of Hp1-1 with P. falciparum infections, (Minang et al., 
2004) found that  the Hp1-1 phenotypes had higher prevalence in placental infection by P. 
falciparum in pregnant women at delivery in western Cameroon. 
1.15. Objectives and Specific Aims: 
Haptoglobin polymorphism has not been researched or addressed in Palestine. There is a wealth 
of literature relating the haptoglobin phenotypes with various conditions, diseases and infections. 
All pathogenic microorganisms have developed mechanisms for scavenging iron from 
circulation. The association of pathogenicity of microorganisms and iron has been repeatedly 
reported in literature. Haptoglobin polymorphism has been reported to play an important role in 
infectious diseases and/or protection from it. 
 Therefore, this study has been designed to evaluate the relationship between nasal carriage of S. 
aureus and the different haptoglobin phenotypes among college students at Birzeit University. 
This study is the first one conducted to determine the specific haptoglobin phenotype in S. 
aureus nasal carriage among Palestinian population. The specific aims of this project were: 
i. To determine the rate of nasal carriage among first year college students at Birzeit University. 
ii. Determine the allele frequency of haptoglobin among the Palestinian population. 
ii. Determine the haptoglobin polymorphism among S. aureus nasal carriers and compare it with 
normal population or non-carriers. 
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Chapter 2 
Materials and Methods 
2.1. Sample collection and samples information  
2.1.1. Nasal swabs and processing 
A total of 1500 nasal swabs were collected during the month of September 2012 and August –
October 2013 from 18-20 year old newly admitted students at Birzeit University (Birzeit, 
Palestine). The nasal swabs were collected according to standard procedure and screened for S. 
aureus nasal carriage. A signed consent was obtained from each student prior to enrollment in 
the study.  
The nasal swabs were immediately inoculated on mannitol salt agar (Oxoid, England) and 
incubated at 37
o
C for 24 hours. Mannitol fermenting Gram positive, Catalase positive bacteria 
were primarily considered S. aureus. Definitive confirmation of the identity of the isolates was 
made by the tube coagulase test (bound and free) and the Staphylase test. 
2.1.2. Blood samples  
Blood was collected in EDTA containing tubes from all participants by the peripheral vein 
puncture procedure following aseptic techniques. CBC, Blood grouping and Rh typing were 
done on all samples. Plasma was separated by centrifugation of the EDTA tubes at 3000 rpms for 
15 minutes, separated plasma were stored   at -20°C   for haptoglobin phenotyping. 
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2.2. Starch Gel Electrophoresis of Haptoglobin 
Starch gel electrophoresis is a simple method used for separation and phenotyping of proteins 
and haptoglobin. Starch is safe and considered a simple and useful method for protein 
electrophoresis. A characteristic feature of starch gels is that they exhibit molecular sieving 
effects. Separation occur based on differences in charge, size and shape of the proteins (Na et al., 
2006). For haptoglobin electrophoresis, 12% (w/v) starch gel slabs were prepared with a 
thickness of 8 mm. The starch gels were prepared by dissolving the starch in Tris-citrate buffer 
pH 8.6.  Borate buffer was used as the running gel. The staining solution was made in 0.1 M 
acetate buffer. 
 
 Following is the preparation of the different buffers and staining reagent used in the starch gel 
electrophoresis conducted in our experiments: 
Buffers and reagents 
1. Tris-Citrate Buffer (Gel buffer) 
Citric acid 1.05 g 
Tris base 9.19 g 
H2O  1 liter 
Adjust pH to 8.6 with HCL. 
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2. Borrate buffer (Running Buffer) 
Boric acid 18.6 g 
NaOH  3.12 g 
H2O  1 liter 
Adjust pH to 8.4 with HCl. 
 
Staining Solution 
3-amino-9-ethylcarbazole/N,N-dimethylformamide(AEC/DMF dye) is prepared as follows: 
1. AEC/DMF dye 40 mg AEC + 10 ml DMF 
2. Solution A  11.55 ml glacial acetic acid/L of dH2O 
3. Solution B  16.4 g Na-acetate/L of dH2O 
4. Mix 22.3 ml of solution A with 30 ml solution B and add enough dH2O make a total of 200 
ml and then add the AEC/DMF prepared in step 1. 
5. Add 4 ml of 30% H2O2 to the staining solution in step 4.  
6. The solution is ready to add to the gel for staining for one hour at 37
o
 C. 
7. 5% glacial acetic acid was added to the stained gel.  
 
2.3. Methods 
2.3.1. Preparation of Starch Gels 
Starch gels were prepared at 12% concentration by mixing 30g of dry starch (Sigma) in250 ml 
Gel Buffer (pH 8.6). The suspension was heated on the flame of a Bunsen burner with 
continuous swirling and vigorous agitation until it became thickened and less viscous. The hot 
starch solution was then degassed and poured into the center of the plate Figure 10 and allowed 
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to spread over the surface. The plate was then left for 30 minutes at room temperature to allow 
the starch solidify and polymerize. After solidification, the gel plate was transferred to a 
refrigerator at 4
o
C and kept for 2-4 hours. 
  
2.3.2. Preparation of Hemolyzed Red Blood Cell Suspension 
Whole blood was collected in EDTA lavender top tubes prior to use.  A total of 2 ml whole 
blood was then washed three times with normal saline and centrifuged at 3,000 rpms for 5 
minutes each time. The sediment and washed red cells were lysed by adding 2 ml distilled water, 
vortexed and centrifuged at 13,000 rpms for 5 minutes, the  lysed cells were then aliquoted in 0.5 
ml and used for 2 or 3 successive days. 
 
2.3.3. Hemoglobin-Haptoglobin Complex Formation 
A total of 30ul of plasma from each sample was mixed with 5 ul of the freshly hemolyzed red 
blood cell suspension and incubated at room temperature for 10 minutes. The hemoglobin-
haptoglobin complex is now ready for starch gel electrophoresis. The solidified starch gel was 
cut with a blade approximately 3-4 cm from the cathode . An aliquot of 15-25 ul of fresh 
prepared Hb-HP complex was applied to Whatman filter paper that is 6 mm thick and cut in 0.3 
X 0.5 cm pieces. The soaked Whatman strips were then inserted into the incision made in the gel 
and spaced 2-3 mm apart Figure 10.  
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2.3.4. Electrophoresis 
The starch gel plates with the loaded samples were placed on the platform of the electrophoresis 
apparatus. To prevent evaporation, the gel was covered with thin plastic membrane. Three layers 
of filter paper were placed on each side of the starch gel with the other end placed in the running 
buffer. Electrophoreses was conducted for 2-4 hours at200 to 300 volts/cm and 30 – 40 mA until 
a migration of the complexes reaches 3 -4 cm away from the anode. The gel set up used is shown 
in Figure 9, 10. 
 
 
 Figure 9: Schematic diagram illustrate Starch gel electrophoresis technique  
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              Figure 10: Starch gel apparatus. 
2.3.5. AEC Immunoperoxidase Staining 
After electrophoresis, the top layer of the plate frame and wicks were removed. The gel was then 
cut into two layers of different thickness using fishing thread. The two layers (6 mm thick and 
3mm thick gels) were stained by immunoperoxidase stain as follows: 
- Pour the staining mix (200 ml) to the gel in a staining tray. 
- Place on an oval rocker with gentle agitation. 
- Leave the gel with the staining solution for one hour at 37o C. 
-  Remove the staining solution and discard in a proper container. 
- Stop the staining by adding  5% Acetic acid (200 ml) solution. 
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Interpretation of the gel 
After staining the starch slices of the gel, few banding pattern can be observed as shown in 
Figure 11 . The fastest or more rapidly migrating band is the free haemoglobin.  Free 
haemoglobin  is followed by a band for the haptoglobin–haemoglobin complex . The banding 
patterns for the different haptoglobin phenotypes as shown in Figure 11 are interpreted as 
follows: 
 Hp1-1 shows single large banding close to the free haemoglobin band. 
 Hp2-1 shows several small banding pattern trailing behind the free hemoglobin front. 
 Hp2-2  shows a characteristic polymeric pattern of the largest and slowest band pattern distinct 
from the haemoglobin front band.  
 
 
Free haemoglobin front 
 
  
 
     
 
 
Hp1-1               Hp2-2                   Hp2-1 
Figure 11: Electrophoresis pattern of Haptoglobin phenotypes. 
 
 
 
 
 
Migration direction  
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2.4. Allele Frequency Calculation: 
Allele frequencies of the haptoglobin genes were determined by gene counting and the goodness 
of fit of the genotype distribution according to the Hardy-Weinberg equilibrium.  
2.5. Statistical Analysis 
Data were statistically analyzed using SPSS (Statistical Package for Social Science) (version 17; 
Inc.,  Chicago.  IL).  The  qualitative  data were expressed as frequency and percent, One way 
analysis of Variance (ANOVA) test was used for comparison between three or more groups Chi-
square (X2) test was used to compare the qualitative variables. The allele frequencies were 
calculated for a two-allele system and differences in haptoglobin genotype and subtype 
frequencies between groups were compared using (X2) test. P-value was considered statistically 
signiﬁcant when it is less than 0.05. 
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Chapter 3 
Results 
 
3.1. Staphylococcus aureus nasal carriage rate 
This study was conducted on nasal swabs collected from a total of 1500 first year college 
students admitted at Birzeit University (Birzeit, Palestine) between 2012 and 2014.The nasal 
swabs were cultured and nasal carriage of S. aureus was determined. Furthermore, whole blood 
was collected from each participating student to determine the prevalent phenotypes of 
haptoglobin in S .aureus carriers and controls.  
As shown in Figure 12, Nasal carriage was seen in 21.5% (324/1500). Haptoglobin phenotyping 
was determined for 224 S. aureus carriers and 99 controls. The results for the nasal carriage and 
haptoglobin phenotypes are shown in the following Figure 12 and Table3 
 
Figure 12: Rate of S. aureus carriers in the total sample. 
 
 
 
Total samples 
78.5% 
S.aureus 
21.5% 
S.aureus nasal carriage distribution 
among study individuals  
Total samples S.aureus 
45 
 
Table 3:  Rate of S. aureus nasal carriage in the al sample collected. 
 
 
 
 
 
3.2. Haptoglobin polymorphism among cases and control  
Haptoglobin phenotyping was done on 323 samples using starch gel electrophoresis. 
Haptoglobin polymorphism was determined for 269 samples. The remaining 54 samples gave 
un-interpretable results. The starch gel electrophoresis results found for Hp polymorphism is 
shown in Figures 13. Figure 13 shows the electrophoresis patterns of the haptoglobin proteins 
according to their genotypes. Hp 1-1 shows a fast migrating band corresponding to the small Hp 
1 dimer, and Hp 2-2 displays multiple slow migrating bands representing polymers consisting of 
Hp 2 proteins. Hp 2-1 has a fast migrating band and several slow migrating bands. 
  
 
Figure 13: Starch gel electrophoresis showing the various phenotypes of haptoglobin. 
 
 No. of positive  Percent  
S.aureus carrier 323/1500 21.6% 
Control  1177 78.4% 
Total  1500 100% 
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The Hp phenotypes have been determined for S. aureus carriers (163 females and 61 males) and 
controls (77 females and 22 males). Phenotyping for the majority of the samples has been 
conducted under the supervision of Dr. Professor Joris Delanghe in his laboratory at Gent 
University Hospital, Belgium. The remaining sample has been analyzed in the Molecular 
Diagnostic Center in Birzeit University with continuous consultation with Professor Dr. De. 
Delanghe and Dr. Mohammad Farraj. The results are shown in Figure 14. The results shown in 
the figure can be summarized in the high expression of Hp 2-1 in the controls. It is also apparent 
among the control group that the rate of Hp 2-2 phenotype is lower than Hp 2-1. On the other 
hand, the carrier group has consistently higher frequency of Hp 2-2 than the other phenotypes. 
Hp 2-1 phenotype has been less expressed among carriers as compared to the controls. Hp 1-1 
phenotype has the least expression among the female control group.  
 
Figure 14: Haptoglobin phenotype among S. aureus carrier and control population 
Hp1-1 % Hp 2-1% Hp2-2 % 
S.aureus positive  15.0% 43.5% 41.5% 
Control 11.0% 49.0% 40.0% 
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 Haptoglobin phenotype distribution in a 
sample and control 
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The results of haptoglobin polymorphism for S. aureus carriers and the control group are 
summarized in Table 4. Hp1-1 frequency was 12% in S. aureus carriers and 10% in the control 
group, while 34% Hp2-1 for S,aureus carriers and 44.4% in the control group.  The frequency of 
Hp2-2 was 34% for S. aureus carriers and 35.5% for the control group. The phenotypes of 20% 
of the  S. aureus carriers could not be determined using the starch gel electrophoresis method and 
10% of control group as well. 
 
Table 4 : Distribution of haptoglobin polymorphism between. S aureus carriers and control groups 
among Birzeit University students. 
 Haptoglobin phenotypes   
Case Total 
Number 
Hp 1-1 % Hp 2-1 
(%) 
Hp 2-2 % Undetectable 
% 
P-value 
S. aureus 
positive 
224 (27)12% (77)34% (76)34% (44)20% >0.05 
Controls 99 (10)9.9 % (44)44.4 (35)35.4% (10)10% >0.05 
Total 323 37 121 111 54  
 
If we neglect the undetected samples in both control and case groups, phenotype frequency 
distribution between the two groups will change as shown in Table 5. 
Table 5: Haptoglobin phenotype distribution in a sample and control without undetectable samples  
  Haptoglobin 
phenotypes 
  
Case Total Number Hp1-1 % Hp 2-1% Hp2-2 % 
S.aureus positive  180 15% 43.% 42% 
Control 89 11% 49% 40% 
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Haptoglobin polymorphism has been determined for the male and female participants in the 
study.  The results are shown for both cases and controls in the Table 6 below. There was no 
significant difference (P>0.05) between female carriers of S .aureus and control group as shown 
in Figure 15. However, there was a significant difference (P=0.015) when S. aureus male carriers 
compared to the male control group showing higher expression of Hp2-2  
Table 6: Haptoglobin polymorphism according to gender among the case and control groups. 
S. aureus Carriers  
Gender/Phenotype Hp1-1 %   
(No) 
Hp2-1 Hp2-2 Undetectable P-value 
Female s   163 10.5         (17) 38         ( 62 )  35.5       (58) 16        (26) NS 
Males        61 16.4         (10) 24.6      (15) 29.5        (18) 29.5      (18) 0.015 
Total        224 27 77 76 44  
Control  
Females     77 6.5         (5) 41.5     (32) 39          ( 30) 13      ( 10) NS 
Males         22 22.7      ( 5) 54.6    ( 12) 22.7         ( 5) 0 0.015 
Total           99 10 34 35 10  
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Figure 15: Different hatpoglobin phenotypes for S.aureus and case in female population  
 
 
Figure 16: Different haptoglobin phenotypes for S.aureus and control group in male population 
 
3.3. Allele Frequency of Haptoglobin 
Allele frequency of haptoglobin has been reported to be dependent on race (Carter & Worwood, 
2007). Reported Hp
1
 allele frequencies among Arabs living in Israel, Saudi Arabia and Iraq were 
0.36, 0.45 and 0.29 respectively as shown in Table 6 Allele frequency among Palestinian control 
population tested in this project who are living in the West Bank has been determined as 0.36 for 
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Hp
1 
and 0.64 for Hp
2
 allele. Allele frequency for the Palestinian population nasal carriers of S. 
aureus was similar to the control group as shown in Table 7.  
Table 7: The Frequency of Haptoglobin  Allele  in  S.aureus positive and  Control  Groups. 
Hp  allele 
 
Frequency 
 
 
 
 S.aureus Control  
Hp1 
 
0.37 0.36 
Hp2 0.63 
 
0.64 
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Chapter 4 
Discussion 
 4.1. Prevalence of S. aureus nasal carriage among study population: 
S. aureus is a commensal that colonizes several parts of the human body and mucus membranes 
and a common cause of nosocomial and community acquired infections as well. The anterior 
nares are the most frequent site for S. aureus colonization and commonly correlated with clinical 
infections by this organism (Wertheim et al., 2005) and subsequent evolution of methicillin 
resistant strains (MRSA).  The prevalence of nasal carriage of S. aureus among the Palestinian 
population has previously been determined to be 25% to 30% (Kaibni et al., 2009). In this study, 
the prevalence of nasal carriage was 21.5%.The main aim of this project was not to determine the 
prevalence of S. aureus nasal carriage but to correlate it with haptoglobin polymorphism. The 
prevalence of nasal carriage in this study was 21.5%, lower than previously reported. This 
indicates better management and improved hygiene measures taken to curb the nasal carriage of 
this organism. 
There are three different states for S. aureus nasal carriage that can be classified as: persistent 
carriage, intermittent carriage, and no carriage. This study didn’t provide insight into 
staphylococcal carriage states of the studied population. Nouwen et al., 2004 suggested that 
Persistent S. aureus nasal carriage has a higher risk of infection, whereas intermittent carriers and 
non-carriers have lower risk (Nouwen et al., 2004). 
Nasal carriage state can be determined by obtaining two samples one week apart with results 
confirming the presence of S. aureus. This was considered the reference procedure to accurately 
predict the persistent S. aureus carriage state with a reliability of 93.6% (Nouwen et al., 2004). 
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Therefore, this method should be used in studies concerning the determination of S. aureus nasal 
carriage state. 
4.2. Haptoglobin phenotypes in nasal carriage of S. aureus: 
Several studies have demonstrated the relation of Hp polymorphism with susceptibility to 
infections and other diseases and severity of clinical symptoms (Melamed-Frank et al., 2001). 
However, to the  best  of  our knowledge through literature searches,  the  correlation  between  
Staphylococcus aureus  nasal carriage   and Hp  has  not  yet  been  studied .  
The Hp polymorphism in the sample tested in this study has been determined for S. aureus 
carriers (163 females and 61 males) and controls (77 females and 22 males) by the starch gel 
electrophoresis method. In  the  present  study, we   found   that   the   individuals  carrying S. 
aureus in their anterior nares was non significantly higher with Hp  2-2 and Hp1-1 phenotypes  
than in control group ,suggesting  that  people  with  the  Hp2-2  phenotype  are  more  
susceptible  to  S.aureus infections or colonization as  compared  to  the other phenotypes;  Hp 2-
1  phenotype. According to Kristiansen   et   al., this may explained by the higher affinity of the 
Hp-Hb  complex  for CD163 emphasizing the notion of Hp  phenotype-dependence relating S. 
aureus nasal carriage with haptoglobin polymorphism (Kristiansen et al., 2001).The results are 
shown in Figure 15,16 and Table 6 . The striking differences shown in the Figure can be 
summarized in the extremely high expression of Hp 2-1 in the controls which reflects its 
protective effects against infections. It is also apparent among the control group that the rate of 
Hp 2-2 phenotype which is correlated with higher frequency of infections is lower than Hp 2-1. 
On the other hand, the S.aureus carrier group has consistently higher frequency of Hp 2-2 than 
the other phenotypes which may play a protective role. It is also apparent that the Hp 2-1 
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phenotype has been less expressed among carriers as compared to the controls.  Furthermore, 
there were 20% of the cases and 10% of the controls cannot be precisely be phenotyped by starch 
gel electrophoresis method. One interpretation for that could be the presence of Hp
del
 gene in 
some of the samples tested ,and Hp 
del
 could not be identified by the routine  electrophoresis 
methods and requires further molecular identification such as polymerase chain reaction  (PCR). 
The sensitivity of the starch gel method can also contribute to our inability to identify the 
haptoglobin phenotype in the undetectable samples. In addition, the overlapping size of the 
various phenotypes could contribute to this effect. Furthermore, low levels of haptoglobin due to 
hemolysis can also contribute to having this high rate of undetermined haptoglobin phenotypes 
in the sample tested.  
Haptoglobin polymorphism according to gender indicated the presence of significant association 
between S. aureus nasal carrier males and the Hp2-2 phenotype (P= 0.015). However, this 
association was not detected in the female group (P>0.05). 
Haptoglobin polymorphism can be associated with various diseases as well as infections. We 
were unable to associate haptoglobin polymorphism with S. aureus nasal carriage among 
humans. In our study, there was no significant association between S. aureus carriers and control 
group by one way ANOVA (P=0.067) 
 
4.3. Allele frequency 
Variations in allele frequency of the Hp
1
 and Hp
2
 genes have been reported worldwide 
depending on racial origin. The Hp
1
 allele frequency for example varied from about 0.07 in some 
Indian population to over 0.7 among some West African and South American populations 
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(Carter & Worwood, 2007). Limited reports have been found in literature addressing allele 
frequency among Arabs in the Middle East and none was found for Palestinian living in west 
bank and Gaza strip.  Reported haptoglobin allele frequency by Ramot et al. in 1961 and 1962 
was limited to Arabs living in Israel, Iraq and Saudi Arabia(Carter & Worwood, 2007) . It is 
apparent that the allele frequency for haptoglobin among the Palestinians tested in this study 
represents a new finding. We were unable to find in literature the allele frequencies for Hp
1
 and 
Hp
2
 genes for Palestinian population and hence we can’t compare our findings with others. 
However, our results are somewhat similar to allele frequency reported for the Israeli Arab 
population and the Jordanian population Table 1 (Carter & Worwood, 2007; Farhud, 1980). This 
similarity can be expected since considerable numbers of Palestinians are living in Jordan in 
refugee camps or integrated with the Jordanian population since the 1948 expulsion due to Israeli 
occupation.  
Table 8: Distribution of Hp1 gene frequencies in the Middle East adopted from (Farhud, 1980). 
Origin No. tested Hp1 frequency Reference 
Turkish 274 0.25 Hummel, 1970  
Kuwaitis 158 0.  345 Sawhney  (1975) 
Iraquis 118 0. 288 Ramot  et  al  
(1961) 
Iraq  (Jews) 118 0. 29 Ramot  et  al.  
(1962) 
Iraq  (Jews) 197 0.  270 Fried  et  al.  (1963) 
Arabs  (S.  Arabia) 92 0. 445  ) Marengo-Rowe  et  
aI.  (1974 
Israeli  (Arabs) 75 0.  36 Ramot  et  al.  
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(1962) 
Israelis  (Orientals) 345 0.  26 Goldschmidt  et  al.  
(1962) 
Israeli  (Kurds) 113 0.  36 Ramot  et  al.  
(1962) 
Kurdish  Jews 96 0.  300 Fried  et  al.  (1963) 
Israeli  
(Ashkenazim) 
170 0.  34 Ramot  et  al.  
(1962) 
Israeli  
(Ashkenazim) 
499 0.27 Goldschmidt  et  al.  
(1962) 
Ashkenazi  Jews 699 0.  300 Fried  et  al.  (1963) 
Israel  (Iran  Jews) 158 0.  310 Simhai  (1976) 
Yemen  Jews 41 0. 250 Fried  et  al.  (1963) 
Haban  Jews 589 0. 210 Bonn6  et  al.  
(1970) 
Towara  Bedouin 198 0. 429 Bonn6  et  aI.  
(1971) 
Jebelliya Bedouin 95 0. 789 Bonn6  et  al.  
(1971) 
Iranians 627 0. 281 Present  study 
Iranians 360 0. 270 Farhud  &  Walter  
(1972) 
Iranians 34 0.25 Harris  et  al.  
(1959) 
Iranians 97 0.  354 Walter  &  
Djahanschahi  
(1963) 
Iranians 1,016 0. 28 Miyashita  &  
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Ohkura  (1975) 
Iranians  (Caspian  
Littoral) 
448 0. 214 Kirk  et  al.  (1977) 
Iranians 1,566 0. 288 Bajatzadeh  &  
Walter  (1969) 
Iranians l, 020 0. 305 Bajatzadeh  &  
Walter  (1968) 
Iranians 275 0. 296 Sawhney  (1975) 
Iranian  Moslems 429 0. 28 Bowman  (1964) 
Iranian  Zorastrians 145 0.  19 Bowman  (1964) 
Iranian  Ghashquai 117 0.  33 Bowman  (1964) 
Iranian  Jews 91 0.30 Ramot  et  aI.  
(1962) 
Iranian  Jews 101 0. 290 Fried  et  al.  (1963) 
Iranian  Jews 459 0.  320 Tabatabai  (1976) 
Iranian  Armenians 228 0.  344 Tabatabai  (1976) 
 
Recommendations  
Looking into the outcomes of this project, we recommend to expand the study to include a larger 
population and collect a more representative sample accounting for age, gender, type of disease 
among other things. Determination of S. aureus nasal carriage state would add value to the 
project and provide important information to healthcare providers. Additionally, it is important to 
evaluate the antimicrobial susceptibility profiles for the tested S. aureus isolates and associate 
that with haptoglobin polymorphism. Since this project is mainly concerned about the outcome 
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of the battle for iron between the body defense mechanisms and the scavenger pathogens, it 
would be very useful and informative to determine the iron status of the study population. 
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 I tnemhcattA
 
 
 
 الطبية المخبرية  علومال برنامج الماجستير في 
 المشاركة في البحثعلى  موافقة
 ___________________________________________________________
 :عنوان البحث
 egairrac lasan suerua .S gnoma msihpromylop nibolgotpaH
 .stneduts ytisrevinU tiezriB 
 بيرزيت الحاملين لبكتيريا المكورات العنقودية المذهبة في الانف جامعة تعدد اشكال الهابتوجلوبين بين طلبة
 جامعة بيرزيت/ محمد فراج، منذر ميتاني. د  :الباحثون
خذ كمية  قليلة من الدم الذي تم الحصول عليه من خلال الموافقة على  أ.نرغب بمشاركتكم  في هذا البحث:  حيثيات ألبحث
واخذ مسحة من الانف ولمساعدتكم في اتخاذ القرار  . جامعة بيرزيت لطلبة روتينية ت اللعمل الفحوصامن قبل عيادة الجامعة 
 :ما يلي وضح ن  نود أن 
  
 . وتحديد نسبة الحاملين لهذه البكتيريا ASRMلدراسة مدى انتشار : الغرض والإجراءات المتبعة في البحث. 1
 . واخذ مسحة الانف الأدنى من الراحة أثناء سحب الدمالحد عدا عن  لا توجد مخاطر  نوقعهاأية مخاطر يمكن . 2
 . عينةاليتم ترميز س، المشارك  لن يتم استخدام اسم :كيف سيتم الحفاظ على السرية. 3
 . يتم إبلاغ الشخص بالنتيجة والمتابعة مسؤوليته الشخصية : وجود نقص في أي من الفحوصاتأي علاج طبي في حالة . 4
  سنة اولى –الطلبة الجدد :  ألمشاركينعدد .5
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ةقيثولا هذه نم ةعقوم ةخسن ىلع لصحت فوس ،ةكراشملا ىلع تقفاو اذإ .و لاصتلاا كنكميبربتخملا ىلع 2555  ةباجلإل
 راسفتسا يأ ىلع لوح كب صاخلا صحفلا جئاتن.  
ةفرعملا ةدايز يف مهست فوس ثحبلا اذه يف كتكراشم نا . يحصلا عضولا ىلع يباجيا ريثأت اهل نوكيس ةساردلا هذه جئاتنو
 اذهلو ينيطسلفلا عمتجملا يفةكراشملا ىلع ادج كركشن . 
 
كراشملا عيقوت :______________________ 
خيراتلا :__________________________ 
 
Attachment II 
Statistical significance; 
Statistical analysis was performed by Chi square and one way ANOVA using SPSS 17 statistical 
package. The results of the analysis and the significant association between the variables are 
shown in the following Tables and Figures 
Statistical analysis   
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Case * Hp 323 100.0% 0 .0% 323 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 5.866
a
 3 .118 
Likelihood Ratio 6.185 3 .103 
Linear-by-Linear Association 4.184 1 .041 
N of Valid Cases 323   
a. 0 cells (.0%) have expected count less than 5. The minimum expected 
count is 11.34. 
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Symmetric Measures 
 
Value 
Asymp. Std. 
Error
a
 Approx. T
b
 Approx. Sig. 
Nominal by Nominal Phi .135   .118 
Cramer's V .135   .118 
Interval by Interval Pearson's R .114 .049 2.056 .041
c
 
Ordinal by Ordinal Spearman Correlation .079 .053 1.412 .159
c
 
N of Valid Cases 323    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
c. Based on normal approximation. 
 
 
Case Processing Summary 
 Cases 
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Valid Missing Total 
N Percent N Percent N Percent 
Case * Hp * Gender 323 100.0% 0 .0% 323 100.0% 
 
 
 
 
 
 
 
 
Chi-Square Tests 
Gender Value df 
Asymp. Sig. (2-
sided) 
Female Pearson Chi-Square 1.838
a
 3 .607 
Likelihood Ratio 1.909 3 .592 
Linear-by-Linear Association .894 1 .344 
N of Valid Cases 241   
Male Pearson Chi-Square 10.415
b
 3 .015 
Likelihood Ratio 14.221 3 .003 
Linear-by-Linear Association 4.991 1 .025 
N of Valid Cases 82   
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 7.12. 
b. 2 cells (25.0%) have expected count less than 5. The minimum expected count is 3.84. 
Symmetric Measures 
70 
 
Gender Value 
Asymp. Std. 
Error
a
 
Approx. 
T
b
 
Approx. 
Sig. 
Female Nominal by 
Nominal 
Phi .087   .607 
Cramer's V .087   .607 
Interval by 
Interval 
Pearson's R .061 .062 .945 .345
c
 
Ordinal by 
Ordinal 
Spearman 
Correlation 
.063 .063 .976 .330
c
 
N of Valid Cases 241    
Male Nominal by 
Nominal 
Phi .356   .015 
Cramer's V .356   .015 
Interval by 
Interval 
Pearson's R .248 .059 2.292 .025
c
 
Ordinal by 
Ordinal 
Spearman 
Correlation 
.130 .093 1.177 .243
c
 
N of Valid Cases 82    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
c. Based on normal approximation. 
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One way ANOVA analysis foe S .aureus sample compared with control sample according to 
gender  
ANOVA 
 
Sum of 
Squares df 
Mean 
Square F P value 
Case Between 
Groups 
.279 1 .279 1.311 .253 
Within Groups 68.377 321 .213   
Total 68.656 322    
phenotype Between 
Groups 
.400 1 .400 3.389 .067 
Within Groups 31.511 267 .118   
Total 31.911 268    
 
ANOVA test revealed no significant difference between nasal carriers and control group with 
Gender. P o0f <0.05 is significant 
 
 
 
 
 
 
 
 
 
